Background: The aim of this study was to evaluate the histological and immunohistochemical effects of levosimendan on liver injury induced by myocardial ischemia and reperfusion (I/R) in a rat model. Methods: Twenty-four male Wistar Albino rats were randomly divided into the four groups: Group C (Control, n = 6), Group I/R (n = 6), Group BI (I/R group treated with levosimendan before ischemia, n = 6), and Group AI (I/R group treated with levosimendan after ischemia, n = 6). Myocardial I/R was induced by ligation of the left anterior descending coronary artery for 30 min followed by two hours of reperfusion in I/R and I/R+Levosimendan groups. At the end of the study, liver tissue samples were obtained for histopathological and immunohistochemical examination. Results: Masson Trichrome staining revealed signifi cant hepatocyte degeneration and necrosis most marked in portal acinus Zone 3, especially around the central veins in Group I/R. Histopathological changes in Group AI were more similar to the changes in Group I/R. Milder hepatocellular degeneration was found in Group BI, when compared to groups I/R and AI. Immunohistochemical score was found to be signifi cantly higher in Group I/R compared to groups C, BI and AI (p < 0.0001). The scores in groups BI and AI were found to be similar (p = 0.068). Conclusion: Levosimendan ameliorates liver injury induced by myocardial IR, especially when administered before induction of ischemia (Fig. 9, Ref. 37 ). Text in PDF www.elis.sk.
Introduction
Myocardial ischemia and reperfusion (I/R) causes a systemic infl ammatory response affecting multiple remote organs during an open heart surgery. Hepatic injury, an infrequent, but serious complication of cardiac surgery, is believed to be a consequence of free-radical generation in the liver and is associated with high rates of morbidity and mortality (1) (2) (3) (4) .
The incidence of liver injury is increasing worldwide. Viral infection, alcohol or drug toxicity, and many other factors, including I/R, can cause damage to hepatocytes. Therefore, these factors may cause infl ammatory and oxidant reactions in the liver (5) (6) (7) (8) (9) (10) .
Levosimendan is a relatively new inotropic and vasodilator agent used in the management of acute and chronic heart failure (11) . Its positive inotropic effect is mediated by calcium sensitization of contractile proteins, and its vasodilatory and anti-ischemic effects are mediated by the opening of adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells (11) (12) (13) (14) .
The protective effects of levosimendan are not limited to cardiac tissue. It has been suggested that levosimendan also attenuates I/R injury in the spinal cord, lung, and in the renal tissue (15) (16) (17) .
The aim of this study was to investigate histological and immunohistochemical effects of levosimendan on liver as a remote organ during an experimental model of myocardial I/R injury in rats.
Materials and methods

Animals and Experimental Protocol
The experiments were performed in adherence to the National Institutes of Health guidelines on the use of experimental animals. Twenty-four male, Wistar rats, weighing from 250 to 350 g, were housed at constant temperature with 12/12 h periods of light and dark exposure. Animals were allowed to standard rat chow and water ad libitum during an acclimatisation period of at least 5 days prior to use in these experiments. The protocols of this experimental study were approved by the Animal Ethics Committee of Gazi University.
The rats were anesthetized with intramuscular ketamine (80 mg/kg) and xylazine (5 mg/kg) injections. After anesthesia and tracheotomy, a 16 G canula (Medipro Nova Cath ® Istanbul, Turkey) was inserted into the trachea and connected to a Rodent model ventilator (Harvard Apparatus Rodent, Inspira asv, Hollstone, USA) with a tidal volume of 15 mL/kg at a breathing frequency of 80 cycles/min. The chest was shaved and each animal was fi xed in a supine position on the operating table. The chest was opened by a left thoracotomy followed by sectioning the fourth and fifth ribs about 2 mm to the left of the sternum. Positive-pressure artificial respiration was started immediately with a room air, using a volume of 1.5 ml/100 g body weight at a rate of 60 strokes/min. Sodium heparin (500 IU/kg) was administered through the tail vein.
After the pericardium was incised, the heart was exteriorized by a gentle pressure on the right side of the rib cage. The left anterior descending (LAD) branch of the left coronary artery was was permanently ligated by passing an 8-0 silk suture attached to a 10-mm micropoint reverse-cutting needle under the artery. The heart was then carefully replaced in the chest and the rat was allowed to recover for 20 min.
There were four experimental groups (Group C (Control; n = 6), Group IR (ischemia-reperfusion, n = 6), Group L (Levosimendan; n = 6) underwent left thoracotomy and received intravenous Levosimendan without I/R (Simdax 2.5 μg/ml, Abbott®, Orion Pharma, Espoo, Finland) was administrated via 100 μg/kg intraperitoneal route 30 minutes before ligating the left coronary artery 19 and Group IR-L (I/R-Levosimendan; n = 6). A small plastic snare was threaded through the ligature and placed in contact with the heart. The artery could then be occluded by applying tension to the ligature (60 min), and reperfusion was achieved by releasing the tension (120 min). Sham-operated rats were used as controls. All rats were sacrified and then the liver tissues were quickly removed.
Histopathological evaluation
Liver biopsy specimens were fi xed in 10 % neutral buffered formalin for 72 hours at room temperature, dehydrated in graded alcohol and embedded in paraffi n. 4-5 μm sections were cut on a microtome (Leica SM 2000, Germany) and mounted on polylysinecoated slides. Some of tissue samples were stained with Masson Trichrome for the evaluation of ultrastructural changes and the remaining samples were evaluated for inducible nitric oxide synthase (iNOS) expression using immunohistochemical staining.
After incubating overnight at 37 °C then for 1 h at 60 °C, slides were de-waxed by two chances of xylene (10 minutes each). The slides were then placed in 100 %, 96 % and 80 % ethanol for 10 minutes each, followed by two 5 minutes changes of distilled water. Then tissues were circumscribed with a pap pen (Super PAP Pen, PN IM3580, Becman Coulter Company, France). After washing with distilled water and with phosphate buffer saline (PBS, pH = 7.4), endogenous enzyme were blocked using hydrogen peroxide in 10 minutes. Following a PBS wash, slides were blocked using ready to use Ultra block (Cat: 859043, Lot: 903532A, Invitrogen, USA) in 10 minutes, prior to application of a 1:50 concentration of i-NOS (Cat: sc-651, Lot: H1308, Santa Cruz, USA) for 1 hour. Two PBS rinses preceded secondary antibody (Cat: 859043, Lot: 903532A, Invitrogen, USA) application for 10 minutes. After washing with PBS, slides were exposed to streptavidin peroxidase (Cat: 859043, Lot: 903532A, Invitrogen, USA) for 10 min. Then AEC (3-Amino-9-EthylCarbazole, Lot: 911667A, Invitrogen, USA) was used as chromogen. Afterwards, the slides were counterstained with Mayer's haematoxylin. Slides were examined with Photo-light microscope (DCM4000 Image Analyze System, DFC280 Plus Camera and QWin Programme, Leica, Weetlar, Germany).
Statistical analyses
Statistical analyses were carried out using the SPSS version 17.0 statistical software package (SPSS Inc., Chicago, IL). The results were expressed as the mean ± standard deviation (SD). p values < 0.05 were considered as statistically signifi cant in all statistical analyses.
Kruskal-Wallis test was used to evaluate the difference among the independent groups with normal distribution. In case of a difference between the groups, the comparison was made using the Mann-Whitney U test.
Results
Masson Trichrome Staining
In histopathological evaluation of Masson Trichrome stained sections, there were no pathological changes in liver tissue of the control group ( Figs 1A, B, C) .
Portal acinus Zone 1 hepatocytes were in normal histologic structure in the Group I/R. Zone 3 hepatocytes near the central 
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vein were noted to have degenerated structure with vacuolar cytoplasm and pale staining. At a higher magnifi cation, signifi cantly degenerated and necrotic hepatocytes were observed around the central veins and also signifi cant oedema and degeneration were noted in the sinusoids. Zone 1 hepatocytes at the portal acinus near the blood vessels in portal space were structurally normal and the sinusoids, endothelial cells and Kuppfer cells also revealed no pathological changes (Figs 2A, B, C) .
In Group BI, portal acinus Zone 1 and partially Zone 2 hepatocytes were found to be normal, but Zone 3 hepatocytes, particularly the ones near the central veins revealed pale staining with degeneration and necrosis. The evaluation at a higher magnifi cation supported these fi ndings. Milder histopathological changes were observed in the Group BI, when compared to the Group AI ( Figs 3A, B, C) .
In the evaluation at a low magnifi cation, the structures in the portal triad and the central veins were observed to be normal in the Group AI. Although the hepatocytes in portal acinus Zone 1, 2 and 3 showed degeneration with pale staining, the hepatocytes near the portal triad were observed to be structurally normal in some areas. Signifi cant oedema was noted in Zone 3 sinusoids. At a higher magnifi cation, structures of the portal triad and the hepatocytes near this zone were noted to be normal, while the hepatocytes in portal acinus Zone 3 near central veins revealed cytoplasmic degeneration and necrosis. Signifi cant sinusoidal oedema was also observed at this zone ( Figs 4A, B, C) .
Immunohistochemical fi ndings
The results of immunohistochemical evaluation supported the fi ndings Masson-Trichrome staining. I-NOS immunoreactivity was very weak in the control group at low and high magnifi cations ( Figs 5A, B) . In Group I/R, moderate to strong i-NOS expression was observed particularly in portal acinus Zone 3 hepatocytes. This fi nding suggested that hepatocytes of Zone 3 may be the cells affected mostly by I/R. I-NOS immunoreactivity was negative in portal acinus Zone 1 and weak in Zone 2 ( Figs 6A, B) .
In the Group AI, a stronger i-NOS expression was noted particularly in Zone 3 hepatocytes of portal acinus near central veins, whereas the immunoreactivity was found to be moderate in the assessment of i-NOS expression in Group BI ( Figs 7A, B and 8A, B) .
There was a statistically signifi cant difference among the groups, when they were compared among themselves by means of immunohistochemical scores (p < 0.0001). Immunohistochemical score was found to be signifi cantly higher in the Group I/R compared to the groups C, BI and AI (p < 0.0001). Moreover, the immunohistochemical scores were also signifi cantly higher in levosimendan groups than the score in the Group C (p < 0.0001). The scores in groups BI and AI were found to be similar (p = 0.068) (Fig. 9 ).
Discussion
Although restoration of blood fl ow to an ischemic organ is essential to prevent irreversible tissue injury, reperfusion of ischemic areas may contribute to further tissue damage. The generation of reactive oxygen species subsequent to reoxygenation infl icts tissue damage and initiates a cascade of deleterious cellular responses leading to infl ammation, cell death, and ultimate organ failure (18) . I/R injury may extend beyond the ischemic area at risk to include injury of remote non-ischemic organs (19) . The remote effects of I/R are most frequently observed in the pulmonary, renal, hepatic and cardiovascular systems, and can result in the development of the systemic infl ammatory response and multiple organ dysfunction syndromes, both of which account for 30-40 % of the mortality in intensive care units (20) . Hepatic I/R injury was mainly observed following major liver surgery, transplantation, trauma and sepsis and may cause metabolic and structural hepatic damage (21, 22) . Severe early ischemic hepatic injury after cardiac surgery is considered as a rare postoperative complication with limited mention in literature and is likely to signifi cantly complicate the postoperative course of heart surgery patients (23, 24) .
The cardioprotective effects of levosimendan are well-established. The fi rst anti-ischemic effects of levosimendan were published in 1994 in isolated rabbit hearts by Rump et al (25) . The authors showed that the left ventricular pressure and coronary blood fl ow were signifi cantly increased by levosimendan after occlusion of the fi rst postero-lateral branch of the circumfl ex artery for 120min. It has been shown to have an anti-ischemic effect, to prevent the development of arrhythmias during acute myocardial infarction and to decrease myocardial infarct size and produce cardioprotective effects while simultaneously enhancing ventricular contractile function in animal studies (26) (27) (28) (29) (30) (31) . However, no suffi cient data exist about the effects of levosimendan against hepatic ischemia-reperfusion injury. To our knowledge, this is the fi rst study to evaluate the effects of levosimendan on hepatic injury induced by myocardial I/R in an experimental model.
A number of in vitro and in vivo studies including models of acute coronary ischemia and cardiac dysfunction showed that levosimendan provided myocardial protection by inducing preconditioning of the myocardium against peri-operative I/R injury and by involving apoptotic pathway (32) (33) (34) (35) (36) . The fi ndings in Masson Trichrome staining and immunohistochemical evaluation showed that portal acinus Zone 3 was the most affected area from I/R injury and then zones 2 and 1, respectively. Histopathological changes in the Group AI were more similar to the changes in Group I/R and this fi nding showed that the rats administered levosimendan after ischemia were more vulnerable to hepatic I/R injury. Milder hepatocellular degeneration was found in Group BI, when compared to the groups I/R and AI.
Sareila et al reported that levosimendan and dextrosimendan decreased iNOS promoter activity, iNOS expression and NO production (37) . In this study, iNOS levels were found to be signifi cantly lower in levosimendan groups compared to the I/R group. The upregulation of iNOS in Group I/R means that I/R stimulates DNA damage. However, in levosimendan groups, the downregulation of iNOS showed that levosimendan had protective effects on I/R related cell damage. Furthermore, it also showed the benefi cial effect of levosimendan on cellular stress. These pathological fi ndings were well correlated with previously reported studies.
Pagel et al examined and compared the effects of levosimendan, pimobendan, and milrinone on regional tissue perfusion by use of the radioactive microsphere technique in dogs and reported that levosimendan increased blood fl ow to the small intestine and liver and reduced vascular resistance in these organs (38). This result indicated that levosimendan might also increase regional tissue perfusion during I/R.
In conclusion, the results of this study indicated that administration of levosimendan before ischemia might be more effective against hepatic I/R injury. We recognize the limitations of simulating human cardiac surgery induced I/R injury using a rat model. Other aspects of these fi ndings including clinical significance and practical applications merit further experimental and clinical investigations.
